Boston Scientific Corporation (NYSE:BSX) is recommended as one of the Best Stocks to Buy for High Returns Heading into 2026. Analyst William Plovanic reiterated a Buy rating with a price target of $132 after the company released results for its fiscal third quarter on October 22. The company exceeded EPS and revenue estimates by $0.04 and $90.87 million, respectively.

Boston Scientific Corporation (NYSE:BSX) raised its full-year guidance, projecting 20% growth and an adjusted EPS range of $3.02 to $3.04. Key growth drivers include products like Watchman and Farapulse, ongoing investment in growth, and expected label expansions of existing products. The company develops and markets medical devices for various interventional specialties.

While Boston Scientific Corporation (NYSE:BSX) shows potential as an investment, some believe certain AI stocks offer greater upside potential with less downside risk. For those interested in undervalued AI stocks benefitting from Trump-era tariffs, check out the best short-term AI stock. This article is originally published at Insider Monkey.

Read more at Yahoo Finance: Canaccord Genuity Reiterates a Buy on Boston Scientific Corporation (BSX)